Cover Image

Heterogeneity of amino acid profiles of proneural and mesenchymal brain-tumor initiating cells

Glioblastomas are highly malignant brain tumors that derive from brain-tumor-initiating cells (BTICs) and can be subdivided into several molecular subtypes. Metformin is an antidiabetic drug currently under investigation as a potential antineoplastic agent. The effects of metformin on glucose metabo...

Full description

Saved in:
Bibliographic Details
Main Authors: Seliger, Corinna (Author) , Rauer, Lisa (Author) , Wüster, Anne-Louise (Author) , Möckel, Sylvia (Author) , Leidgens, Verena (Author) , Jachnik, Birgit (Author) , Ammer, Laura-Marie (Author) , Heckscher, Simon (Author) , Dettmer-Wilde, Katja (Author) , Riemenschneider, Markus J. (Author) , Oefner, Peter J. (Author) , Proescholdt, Martin (Author) , Vollmann-Zwerenz, Arabel (Author) , Hau, Peter (Author)
Format: Article (Journal)
Language:English
Published: 6 February 2023
In: International journal of molecular sciences
Year: 2023, Volume: 24, Issue: 4, Pages: 1-16
ISSN:1422-0067
DOI:10.3390/ijms24043199
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/ijms24043199
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1422-0067/24/4/3199
Get full text
Author Notes:Corinna Seliger, Lisa Rauer, Anne-Louise Wüster, Sylvia Moeckel, Verena Leidgens, Birgit Jachnik, Laura-Marie Ammer, Simon Heckscher, Katja Dettmer, Markus J. Riemenschneider, Peter J. Oefner, Martin Proescholdt, Arabel Vollmann-Zwerenz and Peter Hau
Description
Summary:Glioblastomas are highly malignant brain tumors that derive from brain-tumor-initiating cells (BTICs) and can be subdivided into several molecular subtypes. Metformin is an antidiabetic drug currently under investigation as a potential antineoplastic agent. The effects of metformin on glucose metabolism have been extensively studied, but there are only few data on amino acid metabolism. We investigated the basic amino acid profiles of proneural and mesenchymal BTICs to explore a potential distinct utilization and biosynthesis in these subgroups. We further measured extracellular amino acid concentrations of different BTICs at baseline and after treatment with metformin. Effects of metformin on apoptosis and autophagy were determined using Western Blot, annexin V/7-AAD FACS-analyses and a vector containing the human LC3B gene fused to green fluorescent protein. The effects of metformin on BTICs were challenged in an orthotopic BTIC model. The investigated proneural BTICs showed increased activity of the serine and glycine pathway, whereas mesenchymal BTICs in our study preferably metabolized aspartate and glutamate. Metformin treatment led to increased autophagy and strong inhibition of carbon flux from glucose to amino acids in all subtypes. However, oral treatment with metformin at tolerable doses did not significantly inhibit tumor growth in vivo. In conclusion, we found distinct amino acid profiles of proneural and mesenchymal BTICs, and inhibitory effects of metformin on BTICs in vitro. However, further studies are warranted to better understand potential resistance mechanisms against metformin in vivo.
Item Description:Gesehen am 31.03.2023
Physical Description:Online Resource
ISSN:1422-0067
DOI:10.3390/ijms24043199

Similar Items